Inventiva IVA
NASDAQ IVA
$3.57 +0.11 (+3.18%)
As of: Oct 2, 2026 · 2:13 PM EDT

Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025)

Updated

Inventiva (IVA) posted Non-Current Deffered Revenue of $146,669 for Q4 2025, up 28.3% from $114,340 a year earlier.

Analysis

Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

Since Q4 2018, Inventiva has reported Non-Current Deffered Revenue for 7 quarters.

  • Annual Non-Current Deffered Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 37.7% (FY2022 to FY2025).
  • In prior years, Inventiva's Non-Current Deffered Revenue was $114,340 in FY2024 (+51.8%), $75,316 in FY2023 (+34.2%) and $56,114 in FY2022.
  • The Q4 2025 figure stands as the highest quarterly Non-Current Deffered Revenue since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 146,669.48
Jun 30, 2025 142,626.92
Dec 31, 2024 114,339.71
Dec 31, 2023 75,315.79
Jun 30, 2023 66,424.39
Dec 31, 2022 56,113.61
Dec 31, 2018 1.91 Mn
API Access

Inventiva Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IVA&period=max&api_key=YOUR_API_KEY